Spots Global Cancer Trial Database for bone loss
Every month we try and update this database with for bone loss cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy | NCT06151028 | Gynecological M... Menopausal Symp... Bone Loss | No intervention | 18 Years - 55 Years | Anhui Provincial Hospital | |
| An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy | NCT06151028 | Gynecological M... Menopausal Symp... Bone Loss | No intervention | 18 Years - 55 Years | Anhui Provincial Hospital | |
| Women With Cancer: An Exercise Study to Promote Health | NCT01102985 | Bone Loss Cancer | aerobic resista... home based heal... | 18 Years - 75 Years | Yale University | |
| Gene-activated Bone Substitute for Maxillofacial Bone Regeneration | NCT03076138 | Bone Cysts Bone Atrophy Bone Deformity Bone Fracture Bone Loss Tooth Loss | Gene-activated ... | 18 Years - 60 Years | Histograft Co., Ltd. | |
| The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | NCT00063609 | Prostate Cancer | zoledronic acid | 18 Years - | Novartis | |
| Bone Loss Treatment From Adjuvant Zoledronate Efficacy | NCT01623908 | Breast Neoplasm... Bone Loss | Zoledronate | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
| Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | NCT00181584 | Bone Loss Prostate Cancer | Zoledronic acid Placebo | 18 Years - | Massachusetts General Hospital | |
| Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | NCT00925600 | Cancer Cataract Low Bone Minera... Osteopenia Osteoporosis Prostate Cancer | Denosumab Placebo | 30 Years - 120 Years | Amgen | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska | ||
| Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | NCT00171340 | Bone Loss Breast Cancer | Zoledronic acid Letrozole | - | Novartis | |
| Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy | NCT00129142 | Prostate Cancer Osteoporosis Fractures | Toremifene Citr... | 50 Years - | GTx | |
| Women With Cancer: An Exercise Study to Promote Health | NCT01102985 | Bone Loss Cancer | aerobic resista... home based heal... | 18 Years - 75 Years | Yale University | |
| Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer | NCT03386812 | Prostate Cancer | 55 Years - 89 Years | University of Texas Southwestern Medical Center | ||
| Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer | NCT00199537 | Prostate Cancer Bone Loss | 40 Years - | Lawson Health Research Institute | ||
| Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy | NCT00485953 | Bone Loss Osteoporosis Breast Cancer | risedronate | 55 Years - | University of Pittsburgh | |
| Bone Loss Treatment From Adjuvant Zoledronate Efficacy | NCT01623908 | Breast Neoplasm... Bone Loss | Zoledronate | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
| Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy | NCT00050011 | Breast Neoplasm... Osteoporosis | Zoledronic Acid Letrozole | 18 Years - 85 Years | Novartis | |
| Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients | NCT00824993 | Hematological M... | Ibandronate Vitamin Supplem... | 18 Years - | M.D. Anderson Cancer Center | |
| Radiographic Evaluation of Secondary Alveolar Bone Grafting in Patients With Alveolar Cleft | NCT04845308 | Alveolar Cleft | 8 Years - | University Hospital, Montpellier | ||
| Evaluating Radiomorphometric Indices and Fractal Dimension of the Pediatric Oncology Patients on Panoramic Images | NCT04213482 | Oncology Bone Loss | Panoramic Radio... | 6 Years - 23 Years | Nuh Naci Yazgan University | |
| Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer | NCT00199537 | Prostate Cancer Bone Loss | 40 Years - | Lawson Health Research Institute | ||
| Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer | NCT00082277 | Breast Cancer | Anastrozole Risedronate Sod... | 55 Years - | AstraZeneca | |
| Gene-activated Bone Substitute for Maxillofacial Bone Regeneration | NCT03076138 | Bone Cysts Bone Atrophy Bone Deformity Bone Fracture Bone Loss Tooth Loss | Gene-activated ... | 18 Years - 60 Years | Histograft Co., Ltd. | |
| Gene-activated Bone Substitute for Maxillofacial Bone Regeneration | NCT03076138 | Bone Cysts Bone Atrophy Bone Deformity Bone Fracture Bone Loss Tooth Loss | Gene-activated ... | 18 Years - 60 Years | Histograft Co., Ltd. | |
| Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors | NCT04472286 | Acute Lymphobla... Pediatric ALL Pediatric Lymph... Bone Loss Metabolic Syndr... Habitual Physic... Precursor Cell ... Lymphoma Leukemia Lymphoid Leukem... Pediatric Osteoporosis Osteoporosis Ri... | 5 Years - 18 Years | University of Nebraska | ||
| Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | NCT00171340 | Bone Loss Breast Cancer | Zoledronic acid Letrozole | - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
